Table 4.
Type of intrauterine/ neonatal samples collected and results.
| Type of samples | n/N* (%) |
|---|---|
| Intrauterine samples | |
| Placenta | 67 |
| Positive results | 8 (11.94) |
| Amniotic fluid | 54 |
| Positive results | 1 (1.85) |
| Umbilical cord blood | 42 |
| Positive results | 1 (2.38) |
| Measurement of SARS-CoV-2 IgM and IgG antibody in umbilical cord blood | 2 |
| Reactive IgM | 0 (0.0) |
| Reactive IgG | 1 (50.0) |
| Neonatal samples | |
| RT-PCR newborn's samples (not specified) | 648 |
| Positive results | 19 (2.93) |
| RT-PCR newborn's oral swabs | 1045 |
| Positive results | 36 (3.44) |
| RT-PCR newborn's anal swabs | 38 |
| Positive results | 5 (13.16) |
| RT-PCR newborn's blood | 20 |
| Positive results | 1 (5.00) |
| Measurement of SARS-CoV-2 IgM and IgG antibody in newborn's blood | 71 |
| Reactive IgM | 4 (5.63) |
| Reactive IgG | 7 (9.86) |
| RT-PCR breast milk | 92 |
| Positive results | 4 (4.35) |
| Measurement of SARS-CoV-2 IgM and IgG antibody in breast milk | 7 |
| Reactive IgM | 5 (71.43) |
| Reactive IgG | 0 (0.0) |
*
Newborns with at least one sample tested.